2026 NPPES data Optometrist NPI 1871046565
Verify on CMS →

KYLE BETTIS

Optometrist in DAYTONA BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
544
Medicare Part D claims · 230 beneficiaries · Optometrist avg: 257
Generic prescribing
53%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.0732/100
▲ 7 pts above national avg 83.1 · [object Object]
Industry payments
$754.69
16 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: KYLE BETTIS is a Optometrist ([object Object]) practicing in DAYTONA BEACH, Florida with a Medicare Part D prescribing footprint of 544 claims across 230 beneficiaries — 47% brand-name prescribing . Their CMS MIPS Final Score of 90.0732/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $754.69 across 16 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: KYLE BETTIS reported a CMS MIPS final score of 90.0732 out of 100, above the 83.1 national average, and filed 544 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

KYLE BETTIS at a glance

High performer (top quartile)

NPI registry status

Active

Issued 07/28/2016

NPI 1871046565

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

544 112% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

90.0732/100 6.973200000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Optometrist compares to other specialties among Florida providers

Florida providers

Optometrist share within Florida

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Florida

Medicare quality performance — MIPS

KYLE BETTIS's 2023 MIPS final score plotted against the Optometrist national average

High performer (top quartile)
MIPS Final Score
90.0732/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 90.0732/100 vs national avg 83.1

0%100%National avg83%90.1%
MIPS final score (Optometrist) — 90.0732/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KYLE BETTIS is a Optometrist provider practicing in DAYTONA BEACH, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1871046565. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KYLE BETTIS appears in the CMS NPPES registry as a Optometrist provider at 2254 W INTERNATIONAL SPEEDWAY BLVD, DAYTONA BEACH, FL, 32114, with a listed phone of (138) 625-2363. NPI 1871046565 was issued on 07/28/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BETTIS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 544 prescription claims written by this provider, covering 230 Medicare beneficiaries and totaling roughly $108K in drug spend, split 47% brand-name and 53% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.0732/100 for the 2023 performance year (Quality 85.224), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2254 W INTERNATIONAL SPEEDWAY BLVD
DAYTONA BEACH, FL 32114

Provider Details

NPI 1871046565
Specialty Optometrist
Gender Male
NPI Issued 07/28/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.0732
Final Score
Avg: 83.1
85.224
Quality
94
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KYLE BETTIS. Source: openpaymentsdata.cms.gov.

Total received

$755

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to KYLE BETTIS. To verify KYLE BETTIS's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

KYLE BETTIS — brand share 47.0%
Specialty average (est.)

47% brand-name claims vs 53% generic, on 544 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

544
Total Claims
$108K
Total Drug Cost
230
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
821
Total Day Supply
21,390
Brand vs Generic
47% brand / 53% generic
Brand Drug Cost
$94K
Generic Drug Cost
$14K
Antibiotic Claims
32

Patient Demographics

Average Patient Age
74.6 years
Avg HCC Risk Score
1.53
Gender Split
57% female / 43% male
Age Distribution
<65: 15, 65-74: 112, 75-84: 78, 85+: 25

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
95
Fluorometholone
40
Brimonidine Tartrate
37
Restasis
Cyclosporine
35
Doxycycline Hyclate
33
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
32
Timolol Maleate
32
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
27
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
27
Xiidra
Lifitegrast
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How KYLE BETTIS fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

KYLE BETTIS's 544 claims are above the specialty average of 257.

Nearby Optometrist Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as BETTIS.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is KYLE BETTIS's specialty?
KYLE BETTIS specializes in Optometrist and practices in DAYTONA BEACH, Florida.
How much does KYLE BETTIS prescribe under Medicare Part D?
In 2023, KYLE BETTIS wrote 544 Medicare Part D claims totaling $108K in drug costs for 230 beneficiaries.
What is KYLE BETTIS's Medicare quality score?
KYLE BETTIS has a CMS MIPS Final Score of 90.0732/100 (Quality: 85.224). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KYLE BETTIS located?
KYLE BETTIS is located at 2254 W INTERNATIONAL SPEEDWAY BLVD, DAYTONA BEACH, FL, 32114. Phone: (138) 625-2363.
What is KYLE BETTIS's NPI number?
KYLE BETTIS's National Provider Identifier (NPI) is 1871046565, issued on 07/28/2016.
Does KYLE BETTIS prescribe more brand-name or generic drugs?
KYLE BETTIS's prescribing is 47% brand-name and 53% generic drugs by claim count, with $94K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does KYLE BETTIS prescribe most often?
Based on 2023 Medicare Part D data, KYLE BETTIS's most frequently prescribed drugs include Latanoprost, Fluorometholone, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KYLE BETTIS accept Medicare?
KYLE BETTIS appears in CMS Medicare data with 544 Part D claims and 230 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KYLE BETTIS's credentials?
KYLE BETTIS's NPI is 1871046565. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology